Venous Thrombosis and Thromboembolism - Part 2
Deep vein thrombosis (DVT) and pulmonary embolism (PE) are relatively common diseases and are amenable to therapy, but with a potentially fatal outcome if untreated. The diagnosis can be made in most patients using noninvasive imaging tests, but limitations exist. The standard first choice of investigation in patients with suspected DVT is compression ultrasonography (CUS). Pre-sonography evaluation – including clinical assessment of patient history and physical, Well’s Score and D-Dimer Assay – is important in clinical screening, as well as for medical and interventional disease management. This course will provide attendees with details of advanced diagnostic protocols and interpretation and updates on medical and interventional disease management.
Original Release Date: September 2020
Review Date: September 2021
Course Expiration Date: September 2022
Cardiologists, Sonographers, Physician Assistants, Nurses, Nurse Practitioners and Respiratory Therapists (Personal Growth).
- Apply the proper protocol for lower extremity duplex ultrasonography.
- Describe compression sonography imaging.
- Examine spectral Doppler imaging and recognize why groin (CFV) waveforms are important to accurately interpret.
- Define critical testing values for lower extremity venous duplex ultrasonography.
- Identify aging deep venous thrombosis: acute and subacute DVT vs. chronic venous fibrosis.
- Describe lower extremity duplex ultrasonography, examine its possible use as a primary screening tool in the diagnosis of PE and recognize its limitations.
- Identify interventional PE and DVT disease management: lysis and extraction.
- Review the updated criteria for the use of lysis and extraction.
Brian J. Schiro, M.D.
Medical Director, Noninvasive Lab, Baptist Hospital
Vascular and Interventional Radiologist, Miami Cardiac & Vascular Institute
Brian J. Schiro, M.D., speaker and conference director of this educational activity, disclosed that he receives grant/research support from Medtronic and that he is a member of the speakers’ bureau for Penumbra and Sirtex. Dr. Schiro has also disclosed that his lecture will include discussion of off-label or unapproved usage.
Elliott J. Elias, M.D., conference director of this educational activity, disclosed that he is a member of the speakers’ bureau for Abbott Laboratories, and his participation will not include discussion of off-label or unapproved product usage.
Muhammad Hasan, moderator of this educational activity, has no relevant financial relationship with ineligible companies* to disclose, and that his participation will not include discussion of off-label or unapproved product usage.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Respiratory Therapy
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.